COQ2 nephropathy: a treatable cause of nephrotic syndrome in children
Michelle C. Starr(Indiana University School of Medicine), Christina Lam(Seattle Children's Hospital), Austin Larson(Children's Hospital Colorado), Coral D. Hanevold(Seattle Children's Hospital), Jens Goebel(University of Colorado Anschutz Medical Campus), Jenny Thies(Seattle Children's Hospital), Angela Sun(Seattle Children's Hospital), Johan L.K. Van Hove(Children's Hospital Colorado), Laura S. Finn(Seattle Children's Hospital), Irene J. Chang(Seattle Children's Hospital), Sangeeta Hingorani(University of Washington)
Cited by 43
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|808
Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society
|Genetics in Medicine|2014|605
Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of Microglia
|The American Journal of Human Genetics|2019|263
Targeted long-read sequencing identifies missing disease-causing variation
|The American Journal of Human Genetics|2021|239
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
|Journal of Clinical Investigation|2019|238